Hyperbaric oxygen therapy at Sync: a clinical resource for your cases.

For a surgeon managing a threatened flap, a marginal-perfusion closure, or a patient with a history of radiation to the operative field, immediate access to hyperbaric oxygen is a genuine clinical resource — not a convenience. Compromised grafts and flaps are a recognized indication, and the clinical value is time-sensitive: the sooner a threatened flap is treated, the better positioned it is. Having chambers in the same accredited facility removes the cross-town referral delay that often makes HBOT impractical exactly when it matters most.

Operating three chambers — rather than the single chamber most facilities run — means prescribed series schedule promptly and consistently, without the waitlist that undermines time-dependent protocols.

HBOT is FDA-recognized and UHMS-approved for a defined set of indications (15th edition, UHMS Hyperbaric Medicine Indications Manual). Those most relevant to surgical and procedural practice include:

• Compromised skin grafts and flaps — adjunctive support for grafts and flaps with compromised perfusion.
• Delayed radiation injury — soft tissue and bony necrosis (e.g., osteoradionecrosis, soft-tissue radionecrosis), including pre- and post-operative management in previously irradiated fields.
• Selected problem wounds — including diabetic lower-extremity wounds meeting clinical criteria (e.g., Wagner grade ≥3 unresponsive to standard care).
• Refractory osteomyelitis.
• Chronic/acute conditions on the recognized list — including clostridial myonecrosis (gas gangrene), acute traumatic ischemias (crush injury, compartment syndrome), and thermal burns.
• Avascular necrosis — the newest UHMS-approved indication (15th edition).

Use outside recognized indications remains available at the ordering physician's clinical discretion; we're transparent with patients about which category applies.

HBOT raises dissolved plasma oxygen via Henry's law, delivering oxygen to tissue that compromised perfusion cannot supply through hemoglobin alone. Downstream, the literature describes HIF-1α/VEGF-mediated angiogenesis, enhanced fibroblast activity and collagen synthesis (oxygen-dependent), edema reduction, and improved oxygen-dependent leukocyte function. These are the mechanisms underlying its recognized role in compromised grafts/flaps and problem wounds.

Treatment is delivered in prescribed series, generally at 2.0–2.5 ATA for 90–120 minutes per session. Series length is indication-dependent and physician-determined — for example, delayed radiation injury protocols commonly run 30–60 sessions. Your treatment plan governs; our medical staff will confirm pressure, duration, and session count for each patient.

• Three hard-shell, FDA-cleared chambers: one lay-down (monoplace), one single sit-up, and one two-person chamber.
• Transparent construction with continuous two-way communication and staff monitoring throughout each session.
• Delivered inside an accredited ambulatory surgery center with certified hyperbaric staff, physician supervision, and NFPA 99–compliant fire-safety protocols.

1. Call 702-610-3343 and ask for the hyperbaric coordinator. Written orders can be faxed on request — call first and we'll route them to the right line.
2. Send the order and relevant history. Our medical staff confirms the indication, screens for contraindications, and sets the protocol.
3. Your patient remains under your care. We deliver the prescribed series and report back to your office; we don't redirect your patient's surgical care.
4. Urgent cases: for a threatened flap or graft, call directly — we accommodate urgent cases on short notice, including for surgeons who don't (yet) operate at Sync.

You keep the patient relationship. We treat to your order, document each session, and communicate status and completion back to your office. For cases where you're operating at Sync, HBOT integrates directly into the peri-operative plan.

Hyperbaric coordinator: 702-610-3343
Sync Surgery Center · 7650 W Sahara Ave, Las Vegas, NV 89117

Consumer-facing information for patients considering HBOT is available at Sync Hyperbaric.